Roche Completes Acquisition of BioVeris
Roche Diagnostics today announces that it has completed its acquisition of BioVeris. Roche signed the merger agreement with BioVeris for approximately $600 million on April 4, 2007. This means Roche Diagnostics now owns the patents for Electrochemiluminescence (ECL) technology and can expa...Roche - Roche to acquire BioVeris to expand its leading ECL ...
Roche and BioVeris Corporation announced today that they have signed a ... By acquiring BioVeris, Roche will own the complete patent estate of the ...The Path From BioVeris™ to Meso-Scale Discovery (MSD®)
The recent acquisition of BioVeris™ by Roche as well as Roche's announcement ... long-term BioVeris™ projects. ... The BioVeris™ to MSD® conversion is easy, ...